Imugene Limited (ASX:IMU)
Australia · Delayed Price · Currency is AUD 0.0370
+0.0010 (2.78%)
Oct 21, 2026, 4:10 PM AEDT
Imugene Market Cap
Imugene has a market cap or net worth of 18.12 million as of October 21, 2026. It is the 40,319th most valuable company in the world and the 1,125th biggest in Australia. Its market cap has decreased by 82.99% in one year.
Market Cap
18.12M
Enterprise Value
21.79M
Revenue
2.09M
Global Rank
Country Rank
#1,125 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since September 17, 2002, Imugene's market cap has increased from 7.38M to 18.12M, an increase of 145.56%. That is a compound annual growth rate of 3.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 18.12M | -84.35% |
| Dec 31, 2025 | 115.75M | -57.94% |
| Dec 31, 2024 | 275.18M | -65.11% |
| Dec 29, 2023 | 788.60M | -15.31% |
| Dec 30, 2022 | 931.15M | -59.62% |
| Dec 31, 2021 | 2.31B | 386.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeuroScientific Biopharmaceuticals | 22.60M |
| Algorae Pharmaceuticals | 20.28M |
| Proteomics International Laboratories | 19.02M |
| Radiopharm Theranostics | 17.35M |
| Patrys | 15.72M |
| Argenica Therapeutics | 15.41M |
| Noxopharm | 15.36M |
| EZZ Life Science Holdings | 14.83M |